Dear Dr.
The Zurich and the London Heart House would like to invite you to a Half-Day Hybrid Symposium on
Biomarkers and Machine Learning in Cardiac Disease
Date: Wednesday, November 23rd, 2022
We are looking forward to meeting you during this symposium.
Thomas F. Lüscher, Zurich and London
Alan Maisel, San Diego
Programme
Course Directors: Thomas F. Lüscher, Zurich/London and Alan Maisel, San Diego
Scientific Coordination: Ruth Amstein, Zurich
13:00-15:00 Session 1: Acute and Chronic Coronary Syndromes Chair: Andreas Baumbach, London and Thomas F. Lüscher, London |
||
13:00 | Assessment and selecting appropriate testing | Christian Mueller, Basel |
13:20 | What incremental value does AI/ML provide? | NN |
13:40 |
Diagnosing Type II infarction using AI/ML: Role of current and new biomarkers (HsTn / cMyC) |
Alan Maisel, San Diego |
14:00 | Genetic scores for risk assessment: Ready for prime time? | Heribert Schunkert, Munich |
14:20 | Novel biomarkers for risk assessment | Thomas F. Lüscher, London |
14:40 | Panel discussion | Faculty |
15:00-15:15 Coffee Break |
||
15:15-17:00 Session 2: Chronic Heart Failure Chair: Alan Maisel, San Diego and Ali Vazir, London |
||
15:15 | Assessment and selecting biomarkers for diagnosis and prognostic models | Antoni Bayes-Genis, Barcelona |
15:35 | Imaging modalities: Icremental diagnostic value beyond biomarkers | Brian Halliday, London |
15:55 | Pharmacological management: Do biomarkers help in decision making | Theresa McDonagh, London |
16:15 | Devices in heart failure: ICD and CRT | Shouvik Haldar, London |
16:35 | Panel discussion | |
17:00 | Crossfunctional networking and adjourn |
General Information
Organisation
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90
Venue
The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom
Registration fee: £ 50
You can register on our website here!